A marker of myofibroblasts, α-SMA, has higher expression levels in patients with pulmonary fibrosis and affects the survival rate of patients (Ramos et al., 2001; Qu et al., 2015). The gene discussed is ACTA1; the disease is pulmonary fibrosis.